Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer

  1. Baraibar, I.
  2. Melero, I.
  3. Ponz-Sarvise, M.
  4. Castanon, E.
Journal:
Drug Safety

ISSN: 1179-1942,  0114-5916

Year of publication: 2019

Volume: 42

Issue: 2

Pages: 281-294

Type: Review

DOI: 10.1007/S40264-018-0774-8 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus